SBC Medical Group Holdings Inc
NASDAQ:SBC
SBC Medical Group Holdings Inc
NASDAQ:SBC
Price:
4.15
USD
-0.48%
Market Closed
Market Cap:
$425.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
SBC Medical Group Holdings Inc
NASDAQ:SBC
|
US |
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
Spark New Zealand Ltd
NZX:SPK
|
NZ |
|
Bringspring Science and Technology Co Ltd
SZSE:300290
|
CN |
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
HK |
|
Shenzhen Forms Syntron Information Co Ltd
SZSE:300468
|
CN |
|
C
|
CGS International Inc
OTC:CGSI
|
US |
|
BRD Klee A/S
CSE:KLEE B
|
DK |
|
C
|
Change Healthcare Inc
F:1CB
|
US |
|
BYC Co Ltd
KRX:001460
|
KR |
|
B
|
Bajaj Electricals Ltd
NSE:BAJAJELEC
|
IN |
|
E
|
Eisen und Huettenwerke AG
F:EIS
|
DE |
|
Subsea 7 SA
OTC:ACGYF
|
UK |
Cash Flow Statement
Cash Flow Statement
SBC Medical Group Holdings Inc
SBC Medical Group Holdings Inc
Currency: USD
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
1
|
1
|
1
|
1
|
0
|
(1)
|
(1)
|
40
|
47
|
68
|
71
|
43
|
51
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
12
|
1
|
2
|
3
|
4
|
3
|
3
|
3
|
3
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
4
|
(0)
|
(3)
|
(2)
|
(14)
|
(7)
|
(4)
|
(3)
|
5
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
13
|
13
|
13
|
0
|
|
| Other Non-Cash Items |
(1)
|
(3)
|
(3)
|
(3)
|
3
|
(3)
|
(1)
|
13
|
31
|
25
|
26
|
11
|
(8)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
18
|
16
|
16
|
31
|
30
|
35
|
34
|
36
|
37
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
1
|
0
|
0
|
(8)
|
(14)
|
(12)
|
(26)
|
(47)
|
(52)
|
(68)
|
(89)
|
(27)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(1)
-85%
|
(2)
-108%
|
(2)
-2%
|
51
N/A
|
2
-96%
|
22
+1 038%
|
27
+25%
|
21
-25%
|
19
-9%
|
(9)
N/A
|
(35)
-298%
|
25
N/A
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
(11)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Other Items |
(118)
|
(118)
|
(17)
|
101
|
13
|
98
|
(8)
|
(3)
|
(7)
|
(4)
|
18
|
1
|
(19)
|
|
| Cash from Investing Activities |
(118)
N/A
|
(118)
+0%
|
(17)
+86%
|
101
N/A
|
2
-98%
|
97
+5 335%
|
(9)
N/A
|
(5)
+41%
|
(10)
-86%
|
(8)
+24%
|
15
N/A
|
(1)
N/A
|
(21)
-1 502%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
113
|
0
|
113
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(5)
|
(5)
|
|
| Net Issuance of Debt |
0
|
0
|
1
|
1
|
4
|
1
|
(0)
|
(0)
|
12
|
12
|
12
|
26
|
33
|
|
| Other |
6
|
0
|
(94)
|
(100)
|
3
|
(100)
|
(0)
|
12
|
11
|
11
|
21
|
9
|
10
|
|
| Cash from Financing Activities |
119
N/A
|
0
N/A
|
20
N/A
|
(99)
N/A
|
6
N/A
|
(99)
N/A
|
(0)
+100%
|
12
N/A
|
23
+98%
|
23
-1%
|
30
+32%
|
30
0%
|
38
+28%
|
|
| Change in Cash | ||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(7)
|
(7)
|
(13)
|
0
|
(11)
|
2
|
13
|
(4)
|
(3)
|
|
| Net Change in Cash |
0
N/A
|
0
-54%
|
1
+255%
|
(0)
N/A
|
51
N/A
|
(7)
N/A
|
(0)
+100%
|
34
N/A
|
22
-35%
|
36
+63%
|
49
+37%
|
(10)
N/A
|
39
N/A
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(1)
-85%
|
(2)
-108%
|
(2)
-2%
|
39
N/A
|
1
-97%
|
20
+1 557%
|
25
+20%
|
17
-30%
|
15
-11%
|
(12)
N/A
|
(37)
-210%
|
22
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
